[Male fertility disorders. 1: Diagnostic procedures].

G. Haidl,W. Schill

1991-11-30

Abstract:The current situation in the diagnosis of male fertility disorders is discussed. The importance of an accurate diagnosis to provide a basis for rational therapy is emphasized. In addition, an accurate prognosis can obviate the need for reproductive-medical measures in the female partner in some cases.

What problem does this paper attempt to address?

Design, Synthesis and Biological Evaluation of Novel Thiazole Derivatives As Potent FabH Inhibitors

Peng-Cheng Lv,Kai-Rui Wang,Ying Yang,Wen-Jun Mao,Jin Chen,Jing Xiong,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.bmcl.2009.09.111

IF: 2.94

2009-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:Fatty acid biosynthesis is essential for bacterial survival. Components of this biosynthetic pathway have been identified as attractive targets for the development of new antibacterial agents. FabH, beta-ketoacylacyl carrier protein (ACP) synthase III, is a particularly attractive target, since it is central to the initiation of fatty acid biosynthesis and is highly conserved among Gram positive and negative bacteria. Three series of Schiff bases containing thiazole template were synthesized and developed as potent inhibitors of FabH. This inhibitor class demonstrates strong antibacterial activity. Escherichia coli FabH inhibitory assay and docking simulation indicated that the compounds 11 and 18 were potent inhibitors of E. coli FabH. (C) 2009 Elsevier Ltd. All rights reserved.
Novel Schiff-Base-Derived Fabh Inhibitors with Dioxygenated Rings As Antibiotic Agents

Yang Zhou,Qian-Ru Du,Jian Sun,Jing-Ran Li,Fei Fang,Dong-Dong Li,Yong Qian,Hai-Bin Gong,Jing Zhao,Hai-Liang Zhu

DOI: https://doi.org/10.1002/cmdc.201200587

IF: 3.54

2013-01-01

ChemMedChem

Abstract:Fatty acid biosynthesis plays a vital role in bacterial survival and several key enzymes involved in this biosynthetic pathway have been identified as attractive targets for the development of new antibacterial agents. Of these promising targets, -ketoacyl-acyl carrier protein (ACP) synthaseIII (FabH) is the most attractive target that could trigger the initiation of fatty acid biosynthesis and is highly conserved among Gram-positive and -negative bacteria. Designing small molecules with FabH inhibitory activity displays great significance for developing antibiotic agents, which should be highly selective, nontoxic and broad-spectrum. In this manuscript, a series of novel Schiff base compounds were designed and synthesized, and their biological activities were evaluated as potential inhibitors. Among these 21 new compounds, (E)-N-((3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)methylene)hexadecan-1-amine (10) showed the most potent antibacterial activity with a MIC value of 3.897.81M1 against the tested bacterial strains and exhibited the most potent E.coli FabH inhibitory activity with an IC50 value of 1.6M. Docking simulation was performed to position compound 10 into the E.coli FabH active site to determine the probable binding conformation.
Design, Synthesis, and Structure-Activity Relationships of Pyrazole Derivatives As Potential FabH Inhibitors.

Peng-Cheng Lv,Juan Sun,Yin Luo,Ying Yang,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.bmcl.2010.05.105

IF: 2.94

2010-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:Fatty acid biosynthesis is essential for bacterial survival. FabH, beta-ketoacyl-acyl carrier protein (ACP) synthase III, is a particularly attractive target, since it is central to the initiation of fatty acid biosynthesis and is highly conserved among Gram-positive and - \negative bacteria. Fifty-six 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives were synthesized and developed as potent inhibitors of FabH. This inhibitor class demonstrates strong antibacterial activity. Escherichia coli FabH inhibitory assay and docking simulation indicated that the compounds 1-(5-(4-fluorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl) ethanone (12) and 1-(5-(4-chlorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl) ethanone (13) were potent inhibitors of E. coli FabH. (C) 2010 Elsevier Ltd. All rights reserved.
Discovery of Novel Bacterial FabH Inhibitors (Pyrazol-Benzimidazole Amide Derivatives): Design, Synthesis, Bioassay, Molecular Docking and Crystal Structure Determination

Yan-Ting Wang,Tian-Qi Shi,Jie Fu,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.ejmech.2019.03.026

IF: 7.088

2019-01-01

European Journal of Medicinal Chemistry

Abstract:The enzyme FabH catalyzes the initial step of fatty acid biosynthesis that is essential for bacterial survival. Therefore, FabH has been identified as an attractive target for the development of new antibacterial agents. We present here the discovery of a promising new series of Pyrazol-Benzimidazole amides with low toxicity and potent FabH inhibitory. Twenty-seven novel compounds have been synthesized, and all the compounds were characterized by H-1 NMR, C-13 NMR and MS. Afterwards they were evaluated for in vitro antibacterial activities against E. coli, P. aeruginosa, B. subtilis and S. aureus, along with E. coli FabH inhibition and cytotoxicity test. Some compounds proved to be of low toxicity and potent, especially compound 31 exhibited the most potential to be a new drug with MIC of 0.49-0.98 mu g/mL against the tested bacterial strains and IC50 of 1.22 mu M against E. coli FabH. Eight analogues 16, 28, 30, 31, 33, 34, 35 and 36 with low range MIC against wild type Xanthomonas Campestris exhibited no inhibition against FabH-deficient mutant strain, which firmly proved the class of compounds arrived at antibacterial activity via interacting with FabH. In silica ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) evaluation also pointed out that these compounds are potential for druggability. Further, effective overall docking scores of all the compounds have been recorded, and docking simulation of compound 31 into E. coli FabH binding pocket has been conducted, where solid binding interactions has been identified. (C) 2019 Elsevier Masson SAS. All rights reserved.
Design and Synthesis of Thiazole Derivatives As Potent FabH Inhibitors with Antibacterial Activity.

Jing-Ran Li,Dong-Dong Li,Rong-Rong Wang,Jian Sun,Jing-Jun Dong,Qian-Ru Du,Fei Fang,Wei-Ming Zhang,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.ejmech.2013.11.020

IF: 7.088

2013-01-01

European Journal of Medicinal Chemistry

Abstract:Components of fatty acid biosynthetic pathway have been identified as attractive targets for the development of new antibacterial agents. Compounds of series A (4a-4 g) and series B (5a-5 g) were synthesized by the formation of an amine bond between aromatic acid and 4-phenylthiazol-2-amine or 4-(4-bromophenyl)thiazol-2-amine. These thiazole derivatives have evaluated as potent FabH inhibitors. Nineteen compounds (4b-4h, 4 k, 4 l, 5a-5h, 5k, 5l) are reported for the first time. Most of the synthesized compounds exhibited antibacterial activity in the MTT assay. The MIC value of these compounds ranged from 1.56 μg/mL to 100 μg/mL. Moreover, the tested compounds also showed FabH inhibition ability with IC50 value ranging from 5.8 μM to 48.1 μM. The IC50 values are near the MIC values. Compound 5f has exhibited the best antibacterial and Escherichia coli FabH inhibitory activity. Docking simulation and the QSAR study was conducted for learning about binding mode and the relationship between structure and activity.
Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors

Xiao-Liang Wang,Yan-Bin Zhang,Jian-Feng Tang,Yu-Shun Yang,Ruo-Qi Chen,Fei Zhang,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.ejmech.2012.09.009

IF: 7.088

2012-01-01

European Journal of Medicinal Chemistry

Abstract:Fatty acid biosynthesis is essential for bacterial survival. FabH, β-ketoacyl-acyl carrier protein (ACP) synthase III, is a particularly attractive target, since it is central to the initiation of fatty acid biosynthesis and is highly conserved among Gram-positive and Gram-negative bacteria. A series of acylhydrazone derivatives were synthesized and developed as potent inhibitors of FabH. This inhibitor class demonstrates strong broad-spectrum antibacterial activity. Compounds with potent antibacterial activities were tested for their Escherichia coli FabH inhibitory activity. Especially, compound E9 showed the most potent antibacterial activity with MIC values of 0.39–1.56 μg/mL against the tested bacterial strains and exhibited the most potent E. coli FabH inhibitory activity with IC50 of 2.5 μM. Docking simulation was performed to position compound E9 into the E. coli FabH active site to determine the probable binding conformation.
Design, Synthesis and Antibacterial Activities of 5-(Pyrazin-2-yl)-4h-1,2,4-triazole-3-thiol Derivatives Containing Schiff Base Formation As FabH Inhibitory.

Fei Zhang,Qing Wen,She-Feng Wang,Baloch Shahla Karim,Yu-Shun Yang,Jia-Jia Liu,Wei-Ming Zhang,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.bmcl.2013.11.079

IF: 2.94

2013-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:A series of novel schiff base derivatives (H1–H20) containing pyrazine and triazole moiety have been designed and synthesized, and their biological activities were also evaluated as potential inhibitors of β-ketoacyl-acyl carrier protein synthase III (FabH). These compounds were assayed for antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis and Bacillus amyloliquefaciens and selected compounds among them were tested for their Escherichia coli FabH inhibitory activity. Based on the biological data, compound H17 showed the most potent antibacterial activity with MIC values of 0.39–1.56μg/mL against the tested bacterial strains and exhibited the most potent E. coli FabH inhibitory activity with IC50 of 5.2μM, being better than the positive control Kanamycin B with IC50 of 6.3μM. Furthermore, docking simulation was performed to position compound H17 into the E. coli FabH active site to determine the probable binding conformation. This study indicated that compound H17 has demonstrated significant E. coli FabH inhibitory activity as a potential antibacterial agent and provides valuable information for the design of E. coli FabH inhibitors.
Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle As Potential Β-Ketoacyl-acyl Carrier Protein Synthase III (fabh) Inhibitors.

Yang Zhou,Yu-Shun Yang,Xiao-Da Song,Liang Lu,Hai-Liang Zhu

DOI: https://doi.org/10.1248/cpb.c16-00772

2017-01-01

Abstract:Fatty acid synthesis (FAS) is an essential metabolism during the whole growth and development process of the bacterial. Several key enzymes which involved in this biosynthetic pathway have been considered as useful targets for the development of new antibacterial agents. Among them, beta-ketoacyl-acyl carrier protein synthase III (FabH) is the most magnetic target, since it is central to the initiation of fatty acid biosynthesis and is highly conserved of both Gram-positive and Gram-negative bacteria. Following the previous researches, Schiff-based derivatives with dioxygenated rings and N-heterocycle were synthesized in succession, and their biological activities as potential FabH inhibitors were evaluated in this paper. Among these 15 compounds, compound 2E exhibited the best antibacterial activities with minimum inhibitory concentration (MIC) values 1.56-3.13 mg/mL against the tested bacterial strains and showed the most powerful Escherichia coli (E. coli) FabH inhibitory activities with IC50 of 2.1 mu M. Also the conceivable binding conformation of placing compound 2E into the E. coli FabH active site was affirmed docking simulation.
Discovery and Modification of Sulfur-Containing Heterocyclic Pyrazoline Derivatives As Potential Novel Class of Β-Ketoacyl-acyl Carrier Protein Synthase III (fabh) Inhibitors

Yu-Shun Yang,Fei Zhang,Chao Gao,Yan-Bin Zhang,Xiao-Liang Wang,Jian-Feng Tang,Jian Sun,Hai-Bin Gong,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.bmcl.2012.05.091

IF: 2.94

2012-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:A series of sulfur-containing heterocyclic pyrazoline derivatives (C1-C18; D1-D9) have been synthesized and purified (all are new except one) to be screened for FabH inhibitory activity. Compound C14 showed the most potent biological activity against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Bacillus subtilis (MIC values: 1.56-3.13 mu g/mL), being comparable with the positive control, while D6 performed the best in the thiazolidinone series (MIC values: 3.13-6.25 mu g/mL). They also demonstrated strong broad-spectrum antimicrobial activity. Compounds C14 and D6 exhibited the most potent E. coli FabH inhibitory activity with IC50 of 4.6 and 8.4 mu M, respectively, comparable with the positive control DDCP (IC50 = 2.8 mu M). Docking simulation was performed to position compound C14 and D6 into the E. coli FabH structure active site to determine the probable binding model. The structurally modification of previous compounds and the attempt in innovative target have brought a positive progress. (C) 2012 Published by Elsevier Ltd.
Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents

Hong-Jia Zhang,Di-Di Zhu,Zi-Lin Li,Juan Sun,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.bmc.2011.06.021

IF: 3.461

2011-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of novel cinnamic acid secnidazole ester derivatives have been designed and synthesized, and their biological activities were also evaluated as potential inhibitors of FabH. These compounds were assayed for antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis and Staphylococcus aureus. Compounds with potent antibacterial activities were tested for their E. coli FabH inhibitory activity. Compound 3n showed the most potent antibacterial activity with MIC of 1.56–6.25μg/mL against the tested bacterial strains and exhibited the most potent E. coli FabH inhibitory activity with IC50 of 2.5μM. Docking simulation was performed to position compound 3n into the E. coli FabH active site to determine the probable binding conformation.
Study of acylhydrazone derivatives with deoxygenated seven-membered rings as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors

Yang Zhou,Yin Luo,Yu-Shun Yang,Liang Lu,Hai-Liang Zhu

DOI: https://doi.org/10.1039/c6md00263c

2016-01-01

MedChemComm

Abstract:Fatty acid biosynthesis is essential for bacterial survival. FabH, beta-ketoacyl-acyl carrier protein (ACP) synthase III, is a particularly attractive target, since it is central to the initiation of fatty acid biosynthesis and highly conserved among Gram-positive and Gram-negative bacteria. Following previous studies, a series of acylhydrazone derivatives with deoxygenated rings were synthesized in this work. For all of the 36 analogues synthesized, studies using H NMR, C NMR, MS and elemental analyses were conducted. Their biological activities were also evaluated against two Gram-negative bacterial strains: E. coli and P. aeruginosa, and two Gram-positive bacterial strains: B. subtilis and S. aureus by the MTT method as potential FabH inhibitors. The resulting compound F18 showed the highest antibacterial activity with MIC values of 1.56-3.13 mu g mL(-1) against the tested bacterial strains and was found to be the most potent E. coli FabH inhibitor with an IC50 value of 2.0 mu M. Molecular modeling simulation studies were performed in order to predict the biological activities of compound F18 into the E. coli FabH active site.
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.

Zi-Lin Li,Qing-Shan Li,Hong-Jia Zhang,Yang Hu,Di-Di Zhu,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.bmc.2011.06.049

IF: 3.461

2011-01-01

Bioorganic & Medicinal Chemistry

Abstract:FabH, β-ketoacyl-acyl carrier protein (ACP) synthase III, is a particularly attractive target, since it is central to the initiation of fatty acid biosynthesis and is highly conserved among Gram-positive and Gram-negative bacteria. A series of o-hydroxybenzylamines 1–16 and its corresponding new urea derivatives 17–32 were synthesized and fully characterized by spectroscopic methods and elemental analysis. This new urea derivatives class demonstrates strong antibacterial activity. Escherichia coli FabH inhibitory assay and docking simulation indicated that the compounds 1-(5-bromo-2-hydroxybenzyl)-1-(4-fluorophenyl)-3-phenylurea (18) and 1-(5-bromo-2-hydroxybenzyl)-1-(4-chlorophenyl)-3-phenylurea (20) were potent inhibitors of E. coli FabH.
Design and Synthesis of Potent Inhibitors of Beta-Ketoacyl-acyl Carrier Protein Synthase III (fabh) As Potential Antibacterial Agents.

Lei Shi,Rui-Qin Fang,Zhen-Wei Zhu,Ying Yang,Kui Cheng,Wei-Qing Zhong,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.ejmech.2010.05.033

IF: 7.088

2010-01-01

European Journal of Medicinal Chemistry

Abstract:Twenty new Schiff bases were synthesized by reacting 5-fluoro-salicylaldehyde and primary amine as potent inhibitors of FabH. These compounds were assayed for antibacterial activity against Escherichia coli, Pseudomonas fluorescence, Bacillus subtilis and Staphylococcus aureus. Compounds with potent antibacterial activities were tested for their E. coli FabH inhibitory activity. (E)-4-fluoro-2-((4-hydroxyphenethylimino)methyl)phenol (10) showed the most potent antibacterial activity with MIC of 1.56-6.25 mu g/mL against the tested bacterial strains and exhibited the most potent E. coli FabH inhibitory activity with IC50 of 2.7 mu M. Docking simulation was performed to position compound 10 into the E. coli FabH active site to determine the probable binding conformation. (C) 2010 Elsevier Masson SAS. All rights reserved.
Design and Synthesis of Novel Deoxybenzoin Derivatives As FabH Inhibitors and Anti-Inflammatory Agents

Huan-Qiu Li,Yin Luo,Peng-Cheng Lv,Lei Shi,Chang-Hong Liu,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.bmcl.2010.01.032

IF: 2.94

2010-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:beta-Ketoacyl-acyl carrier protein synthase III (FabH) catalyzes the initial step of fatty acid biosynthesis via a type II fatty acid synthase in most bacteria. The important role of this essential enzyme combined with its unique structural features and ubiquitous occurrence in bacteria has made it an attractive new target for the development of new FabH inhibitors. The synthesis and biological evaluation halide-deoxybenzoins derivatives are described in this Letter. Potent FabH inhibitory and selective anti-Gram-negative bacteria activities were observed in deoxybenzoin derivatives. Furthermore, compound 19 was able to reduce the ECE-induced IL-8 production in gastric mucosal cells significantly. Based on the biological data and molecular docking, compound 19 is a potential FabH inhibitor and anti-inflammatory agent deserving further research. (C) 2010 Elsevier Ltd. All rights reserved.
Unique Aminothiazolyl Coumarins As Potential DNA and Membrane Disruptors Towards Enterococcus Faecalis

Zhong-Lin Zang,Wei -Wei Gao,Cheng-He Zhou

DOI: https://doi.org/10.1016/j.bioorg.2024.107451

IF: 5.307

2024-01-01

Bioorganic Chemistry

Abstract:Aminothiazolyl coumarins as potentially new antimicrobial agents were designed and synthesized in an effort to overcome drug resistance. Biological activity assay revealed that some target compounds exhibited significantly inhibitory efficiencies toward bacteria and fungi including drug-resistant pathogens. Especially, aminothiazolyl 7-propyl coumarin 8b and 4-dichlorobenzyl derivative 11b exhibited bactericidal potential (MBC/MIC = 2) toward clinically drug-resistant Enterococcus faecalis with low cytotoxicity to human lung adenocarcinoma A549 cells, rapidly bactericidal effects and no obvious bacterial resistance development against E. faecalis. The preliminary antibacterial action mechanism studies suggested that compound 11b was able to disturb E. faecalis membrane effectively, and interact with bacterial DNA isolated from resistant E. faecalis through noncovalent bonds to cleave DNA, thus inhibiting the growth of E. faecalis strain. Further molecular modeling indicated that compounds 8b and 11b could bind with SER-1084 and ASP-1083 residues of gyrase-DNA complex through hydrogen bonds and hydrophobic interactions. Moreover, compound 11b showed low hemolysis and in vivo toxicity. These findings of aminothiazolyl coumarins as unique structural scaffolds might hold a large promise for the treatments of drug-resistant bacterial infection.
Synthesis and antibacterial activity of cinnamaldehyde acylhydrazone with a 1,4-benzodioxan fragment as a novel class of potent β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitor.

Xiaoda Song,Yushun Yang,Jing Zhao,Yangjian Chen

DOI: https://doi.org/10.1248/cpb.c14-00485

2014-01-01

Abstract:Fatty acid biosynthesis is essential for bacterial survival. beta-Ketoacyl-acyl carrier protein (ACP) synthase III (FabH), is a particularly attractive antibacterial target, since it is central to the initiation of fatty acid biosynthesis. Three series of 21 cinnamaldehyde acylhydrazone derivatives, A3-9, B3-9, and C3-9, were synthesized and evaluated for FabH-inhibitory activity. Compound B6 showed the most potent biological activity against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Bacillus subtilis (minimum inhibitory concentrations (MICs) values: 1.56-3.13 mu g/mL) and was comparable with the positive control. Docking simulation by positioning compound B6 in the FabH structure active site was performed to explore the possible binding model.
Target identification, and optimization of dioxygenated amide derivatives as potent antibacterial agents with FabH inhibitory activity

Haoyun Chang,Ruiying Ji,Zhiyu Zhu,Yapin Wang,Shaopeng Yan,Dan He,Qike Jia,Peng Huang,Tao Cheng,Rui Wang,Yang Zhou

DOI: https://doi.org/10.1016/j.ejmech.2023.116064

IF: 7.088

2023-12-22

European Journal of Medicinal Chemistry

Abstract:The enzyme FabH plays a critical role in the initial step of fatty acid biosynthesis, which is vital for the survival of bacteria. As a result, FabH has emerged as an appealing target for the development of novel antibacterial agents. In this study, employing the chemical proteomics method, we validated the previously identified skeleton amide derivatives bearing dioxygenated rings, potentially formed through metabolic processes. Building upon the proteomics findings, we then synthesized and evaluated 32 compounds containing N -heterocyclic amides for their antimicrobial activity for future optimizing the deoxygenated amides. Several compounds demonstrated potent antimicrobial properties with low toxicity, particularly compound 25 , which exhibited remarkable potential as an agent with an MIC range of 1.25–3.13 μg/mL against the tested bacterial strains and an IC 50 of 2.0 μM against E. coli -derived FabH. Furthermore, we evaluated nine analogues with relatively low MIC values through cytotoxicity and hemolytic activity assessments, Lipinski's rule-of-five criteria, and in silico ADMET predictions to ascertain their druggability potential. Notably, a detailed docking simulation was performed to investigate the binding interactions of compound 25 within the binding pocket of E. coli FabH, which encouragingly revealed strong binding interactions. Based on our findings, compound 25 emerges as the optimal candidate for in vivo therapy aimed at treating infected skin defects. Remarkably, the application of compound 25 demonstrated a significant reduction in the duration of wound infection and notably accelerated the healing process of infected wounds, achieving an impressive 94 % healing rate by day 10.

chemistry, medicinal
Design, Synthesis and Antimicrobial Activities Evaluation of Schiff Base Derived from Secnidazole Derivatives As Potential FabH Inhibitors.

Yao Li,Chang-Po Zhao,Hua-Ping Ma,Meng-Yue Zhao,Ya-Rong Xue,Xiao-Ming Wang,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.bmc.2013.03.023

IF: 3.461

2013-01-01

Bioorganic & Medicinal Chemistry

Abstract:FabH, β-ketoacyl-acyl carrier protein (ACP) synthase III, is critically important to the initiation of fatty acid biosynthesis and is highly conserved among Gram-positive and Gram-negative bacteria. A series of novel secnidazole derivatives (1–20) were synthesized and fully characterized by spectroscopic methods and elemental analysis. Among these compounds, 6, 8, 11, 13, 14, 16–20 were reported for the first time. These compounds were tested for antibacterial activities against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis and Staphylococcus aureus. The compounds inhibitory assay and docking simulation indicated that compound 20 (E)-2-(2-methyl-5-nitro-1H-imidazol-1-yl)-N′-(3,4,5-trimethylbenzylidene)acetohydrazide with MIC of 3.13–6.25μg/mL against the tested bacterial strains was a potent inhibitor of Escherichia coli FabH.
Synthesis, Antibacterial Activities and Molecular Docking Studies of Schiff Bases Derived from N-(2/4-Benzaldehyde-Amino)Phenyl-N '-Phenyl-thiourea

Hong-Jia Zhang,Xuan Qin,Kai Liu,Di-Di Zhu,Xiao-Ming Wang,Hai-Liang Zhu

DOI: https://doi.org/10.1016/j.bmc.2011.06.077

IF: 3.461

2011-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of novel Schiff base derivatives have been designed and synthesized, and their biological activities were also evaluated as potential inhibitors of FabH. These compounds were assayed for antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, and Staphylococcus aureus. Compounds with potent antibacterial activities were tested for their E. coli FabH inhibitory activity. Compound 3v showed the most potent antibacterial activity with MIC of 1.56–6.25μg/mL against the tested bacterial strains and exhibited the most potent E. coli FabH inhibitory activity with IC50 of 4.3μM. Docking simulation was performed to position compound 3v into the E. coli FabH active site to determine the probable binding conformation.
Evaluation and assessment issues in the diagnosis of attention deficit hyperactivity disorder.

R. Nass

DOI: https://doi.org/10.1016/J.SPEN.2005.12.002

IF: 3.042

2005-12-01

Seminars in Pediatric Neurology

Abstract:

[Male fertility disorders. 1: Diagnostic procedures].

Design, Synthesis and Biological Evaluation of Novel Thiazole Derivatives As Potent FabH Inhibitors

Novel Schiff-Base-Derived Fabh Inhibitors with Dioxygenated Rings As Antibiotic Agents

Design, Synthesis, and Structure-Activity Relationships of Pyrazole Derivatives As Potential FabH Inhibitors.

Discovery of Novel Bacterial FabH Inhibitors (Pyrazol-Benzimidazole Amide Derivatives): Design, Synthesis, Bioassay, Molecular Docking and Crystal Structure Determination

Design and Synthesis of Thiazole Derivatives As Potent FabH Inhibitors with Antibacterial Activity.

Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors

Design, Synthesis and Antibacterial Activities of 5-(Pyrazin-2-yl)-4h-1,2,4-triazole-3-thiol Derivatives Containing Schiff Base Formation As FabH Inhibitory.

Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle As Potential Β-Ketoacyl-acyl Carrier Protein Synthase III (fabh) Inhibitors.

Discovery and Modification of Sulfur-Containing Heterocyclic Pyrazoline Derivatives As Potential Novel Class of Β-Ketoacyl-acyl Carrier Protein Synthase III (fabh) Inhibitors

Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents

Study of acylhydrazone derivatives with deoxygenated seven-membered rings as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors

Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.

Design and Synthesis of Potent Inhibitors of Beta-Ketoacyl-acyl Carrier Protein Synthase III (fabh) As Potential Antibacterial Agents.

Design and Synthesis of Novel Deoxybenzoin Derivatives As FabH Inhibitors and Anti-Inflammatory Agents

Unique Aminothiazolyl Coumarins As Potential DNA and Membrane Disruptors Towards Enterococcus Faecalis

Synthesis and antibacterial activity of cinnamaldehyde acylhydrazone with a 1,4-benzodioxan fragment as a novel class of potent β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitor.

Target identification, and optimization of dioxygenated amide derivatives as potent antibacterial agents with FabH inhibitory activity

Design, Synthesis and Antimicrobial Activities Evaluation of Schiff Base Derived from Secnidazole Derivatives As Potential FabH Inhibitors.

Synthesis, Antibacterial Activities and Molecular Docking Studies of Schiff Bases Derived from N-(2/4-Benzaldehyde-Amino)Phenyl-N '-Phenyl-thiourea

Evaluation and assessment issues in the diagnosis of attention deficit hyperactivity disorder.